Role of retinoic acid and platelet-derived growth factor receptor cross talk in the regulation of neonatal gonocyte and embryonal carcinoma cell differentiation

Endocrinology

Volumn 156, Issue 1, 2015, Pages 346-359

  Manku, Gurpreet ^a,b   Wang, Yan ^d   Merkbaoui, Vanessa ^a   Boisvert, Annie ^a   Ye, Xiaoying ^d   Blonder, Josip ^d   Culty, Martine ^a,b,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; STAT5 PROTEIN; KERATOLYTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STRA8 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; EMBRYONAL CARCINOMA STEM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; GERM CELL; GONOCYTE; MALE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; RAT; SIGNAL TRANSDUCTION; SPERMATOGONIUM; ADULT STEM CELL; ANIMAL; CELL LINE; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TESTIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT STEM CELLS; ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; EMBRYONAL CARCINOMA STEM CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; KERATOLYTIC AGENTS; MALE; MAP KINASE KINASE KINASES; MICE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TESTIS; TRETINOIN;

EID: 84919756172     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1524     Document Type: Article

References (65)

1. CultyM.Gonocytes, the forgotten cells of the germ cell lineage. Birth Defects Res C Embryo Today. 2009;876:1-26
2. Culty M. Gonocytes, from the fifties to the present: Is there a reason to change the name? Biol Reprod. 2013;89(2):46
3. Orth JM, Boehm R. Functional coupling of neonatal rat Sertoli cells and gonocytes in coculture. Endocrinology. 1990;127:2812-2820
4. McGuinness MP, Orth JM. Reinitiation of gonocyte mitosis and movement of gonocytes to the basement membrane in testes of newborn rats in vivo and in vitro. Anat Rec. 1992;233:527-537
5. McGuinness MP, Orth JM. Gonocytes of male rats resume migratory activity postnatally. Eur J Cell Biol. 1992;59:196-210
6. Yoshida S, Sukeno M, Nakagawa T, et al. The first round of spermatogenesis is a distinctive program that lacks the self-renewing spermatogonia stage. Development. 2006;133:495-1505
7. Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J. Carcinoma- in-situ of the testis: Possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl. 1987;10:19-28
8. Wang Y, Culty M. Identification and distribution of a novel plateletderived growth factor receptor β variant: Effect of retinoic acid and involvement in cell differentiation. Endocrinology. 2007;148:2233-2250
9. Schrans-Stassen BH, van de Kant HJ, de Rooij DG, van Pelt AM. Differential expression of c-kit in mouse undifferentiated and differentiating type A spermatogonia. Endocrinology. 1999;140: 5894-5900
10. Rochette-Egly C, Chambon P. F9 embryocarcinoma cells: A cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling. Histol Histopathol. 2001;16(3):909-922
11. Malashicheva AB, Kislyakova TV, Aksenov ND, Osipov KA, Pospelov VA. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after β-irradiation due to p21WAF1/CIP1 degradation. Oncogene. 2000;19:3858-3865
12. Soprano DR, Teets BW, Soprano KJ. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. Vitam Horm. 2007;75:69-95
13. Oulad-Abdelghani M, Bouillet P, Décimo D, et al. Characterization of a premeiotic germ cell-specific cytoplasmic protein encoded by Stra8, a novel retinoic acid-responsive gene. J Cell Biol. 1996; 135(2):469-477
14. Samarut E, Rochette-Egly C. Nuclear retinoic acid receptors: Conductors of the retinoic acid symphony during development. Mol Cell Endocrinol. 2012;348:348-360
15. Rhinn M, Dollé P. Retinoic acid signalling during development. Development. 2012;139:843-858
16. Balmer JE, Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res. 2002;42:1773-1808
17. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J Biol Chem. 1994;269:32023-32026
18. Klinghoffer RA, Mueting-Nelsen PF, Faerman A, Shani M, Soriano P. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol Cell. 2001;7:343-354
19. Loveland KL, Hedger MP, Risbridger G, Herszfeld D, De Kretser DM. Identification of receptor tyrosine kinases in the rat testis. Mol Reprod Dev. 1993;36:440-447
20. Li H, Papadopoulos V, Vidic B, Dym M, Culty M. Regulation of rat testis gonocyte proliferation by platelet-derived growth factor and estradiol: Identification of signaling mechanisms involved. Endocrinology. 1997;138:1289-1298
21. Thuillier R, Wang Y, Culty M. Prenatal exposure to estrogenic compounds alters the expression pattern of platelet-derived growth factor receptors α and β in neonatal rat testis: Identification of gonocytes as targets of estrogen exposure. Biol Reprod. 2003;68:867-880
22. Thuillier R, Mazer M, Manku G, Boisvert A, Wang Y, Culty M. Interdependence of platelet-derived growth factor and estrogen-signaling pathways in inducing neonatal rat testicular gonocytes proliferation. Biol Reprod. 2010;82:825-836
23. Manku G, Mazer M, Culty M. Neonatal testicular gonocytes isolation and processing for immunocytochemical analysis. Methods Mol Biol. 2012;825:17-29
24. Manku G, Wing SS, Culty M. Expression of the ubiquitin proteasome system in neonatal rat gonocytes and spermatogonia: Role in gonocyte differentiation. Biol Reprod. 2012;87(2):44,1-18
25. DymM,Lamsam-Casalotti S, JiaMC,KleinmanHK,Papadopoulos V. Basement membrane increases G-protein levels and follicle-stimulating hormone responsiveness of Sertoli cell adenylyl cyclase activity. Endocrinology. 1991;128(2):1167-1176
26. Thuillier R, Manku G, Wang Y, Culty M. Changes in MAPK pathway in neonatal and adult testis following fetal estrogen exposure and effects on rat testicular cells. Microsc Res Tech. 2009;72:773-786
27. Wilm M, Shevchenko A, Houthaeve T, et al. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature. 1996;379:466-469
28. Rone MB, Liu J, Blonder J, et al. Targeting and insertion of the cholesterol-binding translocator protein into the outer mitochondrial membrane. Biochemistry. 2009;48(29):6909-6920
29. Bryckaert MC, Eldor A, Fontenay M, et al. Inhibition of plateletderived growth factor-induced mitogenesis and tyrosine kinase activity in cultured bone marrow fibroblasts by tyrphostins. Exp Cell Res. 1992;199(2):255-261
30. Strickland S, Smith KK, Marotti KR. Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell. 1980;21:347-355
31. Clifford J, Chiba H, Sobieszczuk D, Metzger D, Chambon P.RXRβ- null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J. 1996;15:4142-4155
32. Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H. Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth. J Lab Clin Med. 2000;135(5):406-412
33. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002; 296:1655-1657
34. Berridge MJ. Phosphatidylinositol hydrolysis: A multifunctional transducing mechanism. Mol Cell Endocrinol. 1981;24:115-140
35. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79(4):1283-1316
36. Bleasdale JE, Bundy GL, Bunting S, et al. Inhibition of phospholipase C dependent processes by U-73, 122. Adv Prostaglandin Thromboxane Leukot Res. 1989;19:590-593
37. Favata MF, Horiuchi KY, Manos EJ, et al. Identification of a novel inhibitor of mitogen-Activated protein kinase kinase. J Biol Chem. 1998;273(29):18623-18632
38. Hiraga Y, Kihara A, Sano T, Igarashi Y. Changes in S1P1 and S1P2 expression during embryonal development and primitive endoderm differentiation of F9 cells. Biochem Biophys Res Commun,. 2006; 344(3):852-858
39. Krawetz R, Kelly GM. Moesin signalling induces F9 teratocarcinoma cells to differentiate into primitive extraembryonic endoderm. Cell Signal. 2008;20(1):163-175
40. Weiler-Guettler H, Yu K, Soff G, Gudas LJ, Rosenberg RD. Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells. Proc Natl Acad Sci USA. 1992;89(6): 2155-2159
41. Ravanko K, Jarvinen K, Helin J, Kalkkinen N, Holtta E. Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts. Cancer Res. 2004;8831-8838
42. Prence EM, Dong JM, Sahagian GG. Modulation of the transport of a lysosomal enzyme by PDGF. J Cell Biol. 1990;110(2):319-326
43. Mosselman S, Looijenga LH, Gillis AJ, et al. Aberrant platelet-derived growth factor α receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis. Proc Natl Acad Sci USA. 1996;93:2884-2888
44. Boulogne B, Levacher C, Durand P, Habert R. Retinoic acid receptors and retinoid X receptors in the rat testis during fetal and postnatal development: Immmunolocalization and implication in the control of the number of gonocytes. Biol Reprod. 1999;61:1548-1557
45. Vernet N, Dennefeld C, Rochette-Egly C, et al. Retinoic acid metabolism and signaling pathways in the adult and developing mouse testis. Endocrinology. 2006;147(1):96-110
46. Germain P, Gaudon C, Pogenberg V, et al. Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists. Chem Biol. 2009;16(5):479-489
47. Araujo J, Logothetis C. Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors. Cancer Treat Rev. 2010;36(6):492-500
48. Benati D, Baldari CT. SRC family kinases as potential therapeutic targets for malignancies and immunological disorders. Curr Med Chem. 2008;15(12):1154-1165
49. Zhuang Y, Faria TN, Chambon P, Gudas LJ. Identification and characterization of retinoic acid receptor β2 target genes in F9 teratocarcinoma cells. Mol Cancer Res. 2003;1:619-630
50. Chiariello M, Marinissen MJ, Gutkind JS. Regulation of c-myc expression by PDGF through Rho GTPases. Nature Cell Biol. 2001; 3(6):580-586
51. Bastien J, Plassat JL, Payrastre B, Rochette-Egly C. The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acidinduced differentiation of F9 cells. Oncogene. 2006;25:2040-2047
52. Hu X, Jin L, Feng L. Erk1/2 but not PI3K pathway is required for neurotrophin 3-induced oligodendrocyte differentiation of post-natal neural stem cells. J Neurochem. 2004;90:1339-1347
53. Mercola M, Wang CY, Kelly J, et al. Selective expression of PDGF A and its receptor during early mouse embryogenesis. Dev Biol. 1990;138:114-122
54. VerheijenMH,WolthuisRM,Bos JL, Defize LH. The Ras/Erk pathway induces primitive endoderm but prevents parietal endoderm differentiation of F9 embryonal carcinoma cells. J Biol Chem. 1999; 274:1487-1494
55. Adachi S, Iwata M. Duration of calcineurin and ERK signals regulates CD4/CD8 lineage commitment of thymocytes. Cell Immunol. 2002;215:45-53
56. Palumbo C, van Roozendaal K, Gillis AJ, et al. Expression of the PDGF β-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and four our understanding of regulatory mechanisms. J Pathol. 2002;196:467-477
57. Basciani S, Mariani S, Arizzi M, et al. Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-α and -β during human testicular development and disease. J Clin Endocrinol Metab. 2002;87:2310-2319
58. Housden BE, Perrimon N. Spatial and temporal organization of signaling pathways. Trends Biochem Sci. 2014;39(10):457-464
59. Stavridis MP, Collins BJ, Storey KG. Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation. Development. 2010;137:881-890
60. Gu P, LeMenuet D, Chung AC, Mancini M, Wheeler DA, Cooney AJ. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol Cell Biol. 2005;25:8507-8519
61. Blake RA, Broome MA, Liu X, et al. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol. 2000;20(23):9018-9027
62. Keating GM, Lyseng-Williamson KA, McCormack PL, Keam SJ. Dasatinib: A guide to its use in chronic myeloid leukemia in the EU. BioDrugs. 2013;27:275-279
63. Nielsen M, Kaltoft K, Nordahl M, et al. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: Tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci USA. 1997;94(13):6764-6769
64. Manabe N, Kubota Y, Kitanaka A, Ohnishi H, Taminato T, Tanaka T. Src transduces signaling via growth hormone (GH)-ActivatedGH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells. Leuk Res. 2006;30(11):1391-1398
65. Drayer AL, Boer AK, Los EL, Esselink MT, Vellenga E. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase. Stem Cells. 2005;23(2):240-251.